|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,311 ILa | -4.10% |
|
+2.42% | -11.30% |
Rekah Pharmaceutical Industry Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was ILS 79 million compared to ILS 72.46 million a year ago. Net income was ILS 0.577 million compared to ILS 0.539 million a year ago.
Basic earnings per share from continuing operations was ILS 0.05 compared to ILS 0.05 a year ago. Diluted earnings per share from continuing operations was ILS 0.05.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.30% | 39.24M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| +5.38% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -3.38% | 3.93B | |
| -2.61% | 3.86B |
REKAH PHARMACEUTICAL INDUSTRY LTD. 
